⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL6556737 | 0.95 | LMNA (0.52) | — | |
| SCHEMBL72471 | 0.86 | LMNA (0.62) | — | |
| SCHEMBL155921 | 0.85 | LMNA (0.63) | — | |
| SCHEMBL31402602 | 0.83 | LMNA (0.60) | — | |
| Hydrochloric Acid SCHEMBL6385125 | 0.83 | LMNA (0.61) | — | |
| SCHEMBL3505201 | 0.83 | LMNA (0.67) | — | |
| SCHEMBL1278227 | 0.81 | LMNA (0.70) | — | |
| SCHEMBL3504067 | 0.81 | LMNA (0.70) | — | |
| SCHEMBL97399 | 0.81 | LMNA (0.70) | — | |
| SCHEMBL3503956 | 0.81 | LMNA (0.70) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717063-A | Preparation and purification method of tulobuterol | 北京泰德制药股份有限公司 | 2021-11-30 | — | — | CN | claimed |
| EP-2956439-B1 | PROCESS FOR PREPARING ATAZANAVIR SULPHATE | CIPLA LTD (IN) | 2019-01-09 | — | — | EP | claimed |
| US-9890121-B2 | Process for preparing atazanavir sulphate | CIPLA LIMITED (IN) | 2018-02-13 | — | — | US | claimed |
| CN-106496756-A | A kind of prefabricated house film | 无锡三帝特种高分子材料有限公司 | 2017-03-15 | — | — | CN | claimed |
| US-20160002166-A1 | Process for Preparing Atazanavir Sulphate | CIPLA LIMITED (IN) | 2016-01-07 | — | — | US | claimed |
| EP-2956439-A1 | PROCESS FOR PREPARING ATAZANAVIR SULPHATE | Cipla Limited (IN) | 2015-12-23 | — | — | EP | claimed |
| CN-103724397-B | The preparation method of a kind of dutasteride's crystal formation I | Qilu Pharmaceutical Co.,Ltd. (CN) | 2015-10-21 | — | — | CN | claimed |
| WO-2014125270-A1 | PROCESS FOR PREPARING ATAZANAVIR SULPHATE | CIPLA HOUSE (IN) | 2014-08-21 | — | — | WO | claimed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| EP-0915899-B1 | PREPARATION OF CRYSTAL FORM II OF CLARITHROMYCIN | ABBOTT LAB (US) | 2004-08-04 | — | — | EP | claimed |
| US-5844105-A | Preparation of crystal form II of clarithromycin | ABBOTT LABORATORIES (US) | 1998-12-01 | — | — | US | claimed |
| EP-0497978-B1 | CEPHALOSPORIN COMPOUNDS AND PRODUCTION THEREOF | KYOTO PHARMA IND (JP) | 1997-04-16 | — | — | EP | claimed |
| US-20250074887-A1 | PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND DERIVATIVES THEREOF | Sea Pharmaceuticals LLC. (US) | 2025-03-06 | — | — | US | disclosed |
| EP-4392397-A2 | PROCESS OF MAKING APOPTOSIS-INDUCING AGENTS | AbbVie Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20240199594-A1 | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2024-06-20 | — | — | US | disclosed |
| US-5026702-A | Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins | DR. KARL THOMAE, GMBH (DE) | 1991-06-25 | — | — | US | disclosed |
| EP-0363223-A2 | 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use | Sankyo Company Limited (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4886814-A | LOWER BLOOD SUGAR | DR. KARL THOMAS GMBH (DE) | 1989-12-12 | — | — | US | disclosed |
| US-4005189-A | Process of suppressing odors employing deodorants containing esters of aliphatic hydroxycarboxylic acids | HENKEL & CIE G.M.B.H. (DT) | 1977-01-25 | — | — | US | disclosed |